Stocks and Investing Stocks and Investing
Fri, August 12, 2022

Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $5 on, Aug 12th, 2022


Published on 2024-10-27 22:38:33 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $6 to $5 on, Aug 12th, 2022.

Jonathan has made no other calls on VINC in the last 4 months.



There are 3 other peers that have a rating on VINC. Out of the 3 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Jonathan


  • Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $8 on, Wednesday, June 8th, 2022
  • Matthew Barcus of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $4 on, Tuesday, June 7th, 2022
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, June 7th, 2022
Contributing Sources